Clinical Trials Browser

Phase 2 × Anatomic Stage I Breast Cancer AJCC v8 × abemaciclib × Clear all

NCT07191717 2025-11-10

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

Phase 2 Not yet recruiting

Anatomic Stage I Breast Cancer AJCC v8